Aclaris Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Aclaris Therapeutics Inc
CIK #0001557746
EDGAR Form CIK 2011 - 2026
10-K [0001557746]
10-Q [0001557746]
3 [0001557746]
4 [0001557746]
8-K [0001557746]
D [0001557746]
SC 13D [0001557746]
SC 13G [0001557746]
Form 13D/13G Filer Form 13D/13G Subject Filed
RA Capital Management LP Aclaris Therapeutics Inc [2026-04-07]
Deep Track Capital LP Aclaris Therapeutics Inc [2026-03-17]
Vanguard Group Inc Aclaris Therapeutics Inc [2025-07-29]
BlackRock Inc Aclaris Therapeutics Inc [2025-07-17]
Millennium Management LLC Aclaris Therapeutics Inc [2025-05-05]
Adage Capital Management LP Aclaris Therapeutics Inc [2025-02-12]
Biosion Inc Aclaris Therapeutics Inc [2024-11-25]
Rock Springs Capital Management LP Aclaris Therapeutics Inc [2024-11-22]
Vivo Opportunity Fund Holdings LP Aclaris Therapeutics Inc [2024-11-21]
Millennium Management LLC Aclaris Therapeutics Inc [2024-02-14]
View All
Form 3/4/5 Subject 2011 - 2026
Aclaris Therapeutics Inc
Molineaux Christopher P
Schiff Andrew N
Mehra Anand
Gowen Maxine
Humphries William D
Milano Vincent
Hall Jesse Wayne
Leonard Braden Michael
Balthaser Kevin
Walker Neal
Kolbeck Roland Wilhelm
Loerop James
Davis Hugh M
Monahan Joseph
Biosion Inc
Reasons Bryan M
Powell Andrew Kenneth William
Manion Douglas J
Cawkwell Gail
Ruffo Frank
Ali-Jackson Kamil
Tananbaum James B
Foresite Capital Management IV LLC
Foresite Capital Management III LLC
Foresite Capital Fund V LP
Foresite Capital Fund III LP
Foresite Capital Fund IV LP
Foresite Capital Management V LLC
Gordon David N
Deerfield Special Situations Fund LP
Deerfield Management Company LP
Deerfield Capital LP
Deerfield Partners LP
Flynn James E
Shanler Stuart
Fair Brett
Powala Christopher
Tullman Stephen A
FMR LLC
Bierly Rick
Vivo Ventures VII Affiliates Fund LP
Vivo Ventures Fund VII LP
Vivo Ventures VII LLC
Kolchinsky Peter
RA Capital Healthcare Fund LP
RA Capital Management LP
Cha Albert
Powell Michael
Sofinnova Management VIII LLC
Sofinnova Venture Partners VIII LP
Akkaraju Srinivas
Healy James
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Aclaris Therapeutics Inc ACRS
Common Stock
2026-03-01 Tax withheld 677 $2.87 1,943
Aclaris Therapeutics Inc ACRS
Common Stock
2026-03-01 Option exercise 2,375
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
2026-03-01 Option exercise 2,375 $0.00
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
2026-02-03 Option exercise 22,025 $0.00
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
2026-02-03 Option exercise 63,475 $0.00
Aclaris Therapeutics Inc ACRS
Common Stock
2026-02-03 Option exercise 18,675
Aclaris Therapeutics Inc ACRS
Common Stock
2026-02-03 Option exercise 63,475
Aclaris Therapeutics Inc ACRS
Common Stock
2026-02-03 Tax withheld 18,611 $3.47 64,580
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
2026-02-03 Option exercise 18,675 $0.00
Aclaris Therapeutics Inc ACRS
Common Stock
2026-02-03 Option exercise 20,875
Aclaris Therapeutics Inc ACRS
Common Stock
2026-02-03 Tax withheld 5,937 $3.47 20,601
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
2026-02-03 Option exercise 20,875 $0.00
Aclaris Therapeutics Inc ACRS
Common Stock
2026-02-03 Option exercise 22,025
Aclaris Therapeutics Inc ACRS
Common Stock
2026-02-03 Tax withheld 6,449 $3.47 22,378
Aclaris Therapeutics Inc ACRS
Employee Stock Option (Right to Buy) · derivative
2026-02-02 Grant 346,800 $0.00
Aclaris Therapeutics Inc ACRS
Employee Stock Option (Right to Buy) · derivative
2026-02-02 Grant 334,900 $0.00
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
2026-02-02 Grant 97,700 $0.00
Aclaris Therapeutics Inc ACRS
Employee Stock Option (Right to Buy) · derivative
2026-02-02 Grant 961,700 $0.00
Aclaris Therapeutics Inc ACRS
Restricted Stock Units · derivative
2026-02-02 Grant 95,700 $0.00
Aclaris Therapeutics Inc ACRS
Employee Stock Option (Right to Buy) · derivative
2026-02-02 Grant 336,300 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com